Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
Clicks: 149
ID: 116826
2019
Monotherapy with lefamulin, a novel, pleuromutilin antibiotic with intravenous and oral formulation options, was noninferior to moxifloxacin for efficacy and ge
| Reference Key |
m2019clinicalefficacy
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | File, Thomas M;Goldberg, Lisa;Das, Anita;Sweeney, Carolyn;Saviski, John;Gelone, Steven P;Seltzer, Elyse;Paukner, Susanne;Wicha, Wolfgang W;Talbot, George H;Gasink, Leanne B; |
| Journal | clinical infectious diseases |
| Year | 2019 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.